Details for New Drug Application (NDA): 215368
✉ Email this page to a colleague
The generic ingredient in CARMUSTINE is carmustine. There are eleven drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the carmustine profile page.
Summary for 215368
Tradename: | CARMUSTINE |
Applicant: | Mylan Labs Ltd |
Ingredient: | carmustine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 215368
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 100MG/VIAL | ||||
Approval Date: | Mar 3, 2023 | TE: | RLD: | No |
Complete Access Available with Subscription